Sadzot-Delvaux, Catherine ; Université de Liège - ULiège > Département des sciences de la vie > Virologie et immunologie - GIGA-M : Coordination scientifique
Language :
English
Title :
A new topical treatment for resistant herpes simplex infections.
Publication date :
1993
Journal title :
New England Journal of Medicine
ISSN :
0028-4793
eISSN :
1533-4406
Publisher :
New England Journal of Medicine, Waltham, United States - Massachusetts
Straus SE, Smith HA, Brickman C, de Miranda P, McLaren C, Keeney RE Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med 1982; 96: 270-277
Erlich KS, Jacobson MA, Koehler JE, Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS): an uncontrolled trial. Ann Intern Med 1989; 110: 710-713
Safrin S, Assaykeen T, Follansbee S, Mills J Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis 1990; 161: 1078-1084
De Clercq E, Holy A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC A novel selective broad-spectrum anti-DNA virus agent. Nature 1986; 323: 464-467
De Clercq E, Holy A Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. Antimicrob Agents Chemother 1991; 35: 701-706
